MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
AIDX — 20/20 Biolabs, Inc. Common Stock
Nasdaq20/20 Biolabs, Inc. Common Stock
$0.41
-0.03(-6.32%)
- O
- 0.43
- H
- 0.45
- L
- 0.41
- V
- 51.99K
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About AIDX
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
IndustrySERVICES-TESTING LABORATORIES
SectorNot available
IPO DateFeb 19, 2026
Employees14
Stock ExchangeNasdaq
Ticker SymbolAIDX
Websitehttps://www.2020biolabs.com
Key Financial Statistics
| Market Cap | $5.55M |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.40 - $50.00 |
| 52-Week Avg Volume | 423.3K |
| VWAP | $0.42 |
| Transactions | 234 |
| Total Recorded Bars | 156 days |